{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T14:50:16Z","timestamp":1788274216197,"version":"build-2803163510"},"reference-count":7,"publisher":"Walter de Gruyter GmbH","issue":"4","license":[{"start":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T00:00:00Z","timestamp":1728432000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,12,23]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec id=\"j_almed-2024-0037_abs_001\">\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>\n                      To describe a variant hemoglobin that interferes with HbA\n                      <jats:sub>1c<\/jats:sub>\n                      analysis by cation exchange HPLC.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_almed-2024-0037_abs_002\">\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>\n                      A 78 years-old Spanish male patient visited the Internal Medicine Clinic for a routine check-up, with HbA\n                      <jats:sub>1c<\/jats:sub>\n                      included to screen for diabetes. He had suffered hypertension and dyslipidemia, and the patient had no\u00a0previous symptoms suggestive of diabetes such as hyperglycemia, weight loss, polydipsia, polyuria or tiredness. Diabetes screening by HbA\n                      <jats:sub>1c<\/jats:sub>\n                      measurement was assessed using cation exchange HPLC and an immunoassay point-of-care analyzer. Routine hemoglobinopathy screening was performed including CBC, HbF and HbA\n                      <jats:sub>2<\/jats:sub>\n                      measurement by cation exchange HPLC and capillary electrophoresis (CE). Further variant characterization was undertaken by DNA sequencing. Discordant HbA\n                      <jats:sub>1c<\/jats:sub>\n                      results were obtained for our subject, with elevated HbA\n                      <jats:sub>1c<\/jats:sub>\n                      of 52\u202fmmol\/mol measured by cation exchange HPLC and a normal level of 34\u202fmmol\/mol by\u00a0immunoassay. Abnormal HbA\n                      <jats:sub>1c<\/jats:sub>\n                      peak shape prompted hemoglobinopathy screening to investigate potential variant interference. A globin gene analysis was performed, and the\u00a0results showed a variant hemoglobin named \u2018Hb Petie Salpetriere\u2019. This variant arises from a Val \u2192 Phe substitution due to a mutation of c.103G&gt;T of the beta-globin gene [BETA34 (B16) Val&gt;Phe; HBB:c.103G&gt;T].\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_almed-2024-0037_abs_003\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      This is the first reported case involving the Hb Petie Salpetriere variant in a Spanish patient. The present results show that the Hb Petie Salpetriere variant can affect the results of HbA\n                      <jats:sub>1c<\/jats:sub>\n                      analysis through ion-exchange HPLC, but not that obtained from the latex agglutination immunoassay. Only ion-exchange HPLC suggested the presence of the Hb variant in this case, suggesting that a careful review of the resulting chromatogram might reveal a potential variant.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1515\/almed-2024-0037","type":"journal-article","created":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T11:41:50Z","timestamp":1728387710000},"page":"447-450","source":"Crossref","is-referenced-by-count":1,"title":["False HbA\n                    <sub>1c<\/sub>\n                    value due to a rare variant of hemoglobin Petie Salpetriere coinherited with alpha thalassemia"],"prefix":"10.1515","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1077-7118","authenticated-orcid":false,"given":"Esperanza","family":"Lepe Balsalobre","sequence":"first","affiliation":[{"name":"Department of Laboratory Service , \u00c1rea de Gesti\u00f3n Sanitaria Norte de Huelva, Hospital de Riotinto, Minas de Riotinto , Huelva , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gema Mar\u00eda","family":"Varo S\u00e1nchez","sequence":"additional","affiliation":[{"name":"Department of Laboratory Service , \u00c1rea de Gesti\u00f3n Sanitaria Norte de Huelva, Hospital de Riotinto, Minas de Riotinto , Huelva , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Rico Rodr\u00edguez","sequence":"additional","affiliation":[{"name":"Department of Laboratory Service , \u00c1rea de Gesti\u00f3n Sanitaria Norte de Huelva, Hospital de Riotinto, Minas de Riotinto , Huelva , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4125-8625","authenticated-orcid":false,"given":"Sandra","family":"Fuentes Cantero","sequence":"additional","affiliation":[{"name":"Department of Laboratory Service , \u00c1rea de Gesti\u00f3n Sanitaria Norte de Huelva, Hospital de Riotinto, Minas de Riotinto , Huelva , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2024,10,9]]},"reference":[{"key":"2025121815520080745_j_almed-2024-0037_ref_001","doi-asserted-by":"crossref","unstructured":"Little, R, La\u2019ulu, S, Hanson, S, Rohlfing, C, Schmidt, R. Effects of 49 different rare Hb variants on HbA1c measurement in eight methods. J Diabetes Sci Technol 2015;9:849\u201356.","DOI":"10.1177\/1932296815572367"},{"key":"2025121815520080745_j_almed-2024-0037_ref_002","doi-asserted-by":"crossref","unstructured":"Moore, JA, Li, BV, Wang, D, Chan, B, King, RI, Florkowski, CM. Hb Westport [\u03b2121 (GH4) Glu>Asp; HBB:c.366A>C]: a novel \u03b2-globin variant interfering with HbA1c measurement,. Clin Biochem 2022;107:62\u20136. https:\/\/doi.org\/10.1016\/j.clinbiochem.2022.05.003.","DOI":"10.1016\/j.clinbiochem.2022.05.003"},{"key":"2025121815520080745_j_almed-2024-0037_ref_003","doi-asserted-by":"crossref","unstructured":"Blouquit, Y, Braconnier, F, Cohen-Solal, M, F\u00f6ldi, J, Arous, N, Ankri, A, et al.. Hemoglobin Petie-Salpetriere beta 34 (B16) Val replaced by Phe. A new high oxygen affinity variant associated with familial erythrocytosis. Biochim Biophys Acta 1980;624:473\u20138. https:\/\/doi.org\/10.1016\/0005-2795(80)90088-4.","DOI":"10.1016\/0005-2795(80)90088-4"},{"key":"2025121815520080745_j_almed-2024-0037_ref_004","unstructured":"Uchida, T, Kinoshita, T, Hirabayashi, N, Saito, H, Harano, K, Harano, T. Hemoglobin Petie-Salpetriere [beta 34 (B16) Val-->Phe] showing erythrocytosis and mild hemolysis in a Japanese man. Int J Hematol 2000;71:221\u20136."},{"key":"2025121815520080745_j_almed-2024-0037_ref_005","unstructured":"Artuso, A, Balter, R, Bonetti, E, Chiara, Z, Ravani, A, Dolcini, B, et al.. The high oxygen affinity haemoglobin Nantes: a family case description. Blood Transfus 2015;13:524\u20137. https:\/\/doi.org\/10.2450\/2014.0206-14."},{"key":"2025121815520080745_j_almed-2024-0037_ref_006","doi-asserted-by":"crossref","unstructured":"Ben\u00edtez Camacho, I, Lameiro Chaves, P, Ropero, P, L\u00e1zaro, J, Gonz\u00e1lez, F, Moro, A. Hemoglobin Valme HBB:c.124T>G: a new hemoglobin variant with diminished oxygen affinity causes interference in hemoglobin A1c measurement in an automated ion-exchange HPLC method. Clin Chem Lab Med 2015;53:e211\u201313. https:\/\/doi.org\/10.1515\/cclm-2014-1028.","DOI":"10.1515\/cclm-2014-1028"},{"key":"2025121815520080745_j_almed-2024-0037_ref_007","doi-asserted-by":"crossref","unstructured":"Zhuang, L, Patel, N, Bryant, S, Kutlar, A, Kutlar, F, Young, AN. Hb Fulton-Georgia [\u03b120(B1)His\u2192Pro; HBA1: c.62A>C]: a new \u03b1-globin variant coinherited with \u03b1-thalassemia-2 (3.7 kb deletion) and Hb SC disease. Hemoglobin 2013;37:481\u20135. https:\/\/doi.org\/10.3109\/03630269.2013.810640.","DOI":"10.3109\/03630269.2013.810640"}],"container-title":["Advances in Laboratory Medicine \/ Avances en Medicina de Laboratorio"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/almed-2024-0037\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/almed-2024-0037\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T15:53:12Z","timestamp":1766073192000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/almed-2024-0037\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,9]]},"references-count":7,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,9,23]]},"published-print":{"date-parts":[[2024,12,23]]}},"alternative-id":["10.1515\/almed-2024-0037"],"URL":"https:\/\/doi.org\/10.1515\/almed-2024-0037","relation":{},"ISSN":["2628-491X"],"issn-type":[{"value":"2628-491X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,9]]}}}